L’Oreal Optimistic About Post-Shutdown Growth, Notes Likely Thinning Of Beauty Field
Executive Summary
“It's unfortunate, but it's the Darwinian side of this industry,” L’Oreal CEO Jean-Paul Agon said on 16 April while discussing newer players’ prospects for survival through the COVID-19 crisis and L’Oreal’s own first-quarter results – down 4.8% like-for-like, but ahead of the market.
You may also be interested in...
L’Oreal To Fuel Continued Dermocosmetics Growth With Skinbetter Science Acquisition
Phoenix, AZ-based Skinbetter Science “has become one of the fastest growing medical-dispensed skincare brands in the United States,” recording nearly $95m in sales for the 12-month period ended 31 August 2022, and shows “great international potential,” according to L’Oreal leadership.
Dermocosmetics Opportunity Beckons: Top 20 Brands Account For Just 35% Of Global Market – IQVIA
The global dermocosmetics market is led by L’Oréal SA with 13.3% share across 20 countries evaluated, followed by Pierre Fabre Group with 7.4%. According to IQVIA Consumer Health, this points to a fragmented market with ample room for innovative, “nimble” brands to enter and nab share.
L’Oreal Powering Down Clarisonic After 16 Years Of Innovation, More Than 15 Million Devices Sold
The decision to close Clarisonic follows a €234m impairment charge recorded in 2016 and comes as L’Oreal faces tough strategic decisions in a global economy ravaged by the COVID-19 crisis.